Cefotaxime therapy of serious bacterial infection in adults.
We evaluated the efficacy, safety, and tolerance of cefotaxime in 35 adults (25 with pleuropulmonary infections, 7 with genitourinary tract infections, and 3 with soft tissue infections). Of these 35 patients, 18 (51.4%) were seriously or critically ill. In vitro susceptibility testing revealed that...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1982
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181908/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6285810/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.3.421 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|